Back
EyePoint Pharmaceuticals Vs. Five Below Industry Stock Comparison
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.64
Seasonality Move:
-1.71%
Sell
28
FIVE
Five Below
Last Price:
$77.64
Seasonality Move:
0.95%
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $6.78. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Five Below (FIVE)
is a Sell
Is Five Below a Buy, Sell or Hold?
-
The current Five Below [FIVE] share price is $75.32. The Score for FIVE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
FIVE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $6.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FIVE Stock Price Chart
What is Five Below's stock price today?
-
The Five Below share price today is $75.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FIVE is experiencing slight selling pressure.
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 62.18 | Buy |
| Chaikin Money Flow: | 417062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.91 - 6.35) | Buy |
| Bollinger Bands (100): | (5.76 - 8.02) | Sell |
FIVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 56.15 | Buy |
| Chaikin Money Flow: | -150205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.46 - 77.22) | Buy |
| Bollinger Bands (100): | (73.12 - 102.8) | Sell |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.25 | Buy |
| 20-day SMA: | 5.52 | Buy |
| 50-day SMA: | 6.04 | Buy |
| 200-day SMA: | 8.11 | Sell |
| 8-day EMA: | 6.28 | Buy |
| 20-day EMA: | 5.94 | Buy |
| 50-day EMA: | 6.18 | Buy |
| 200-day EMA: | 8.38 | Sell |
FIVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.34 | Buy |
| 20-day SMA: | 67.35 | Buy |
| 50-day SMA: | 75.87 | Sell |
| 200-day SMA: | 86.61 | Sell |
| 8-day EMA: | 72.04 | Buy |
| 20-day EMA: | 70.34 | Buy |
| 50-day EMA: | 75.38 | Sell |
| 200-day EMA: | 94.8 | Sell |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Five Below Earnings Growth & FIVE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.35 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.44 per share.
EyePoint Pharmaceuticals Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Five Below Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||